Year |
Citation |
Score |
2015 |
Park JE, Kim TS, Meng L, Bang JK, Kim BY, Lee KS. Putting a bit into the polo-box domain of polo-like kinase 1. Journal of Analytical Science and Technology. 6: 27. PMID 26500787 DOI: 10.1186/s40543-015-0069-y |
0.304 |
|
2015 |
Salanti A, Clausen TM, Agerbæk MØ, Al Nakouzi N, Dahlbäck M, Oo HZ, Lee S, Gustavsson T, Rich JR, Hedberg BJ, Mao Y, Barington L, Pereira MA, LoBello J, Endo M, ... ... Meng L, et al. Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein. Cancer Cell. 28: 500-14. PMID 26461094 DOI: 10.1016/J.Ccell.2015.09.003 |
0.313 |
|
2015 |
Wang X, Ding J, Meng LH. PI3K isoform-selective inhibitors: next-generation targeted cancer therapies. Acta Pharmacologica Sinica. PMID 26364801 DOI: 10.1038/aps.2015.71 |
0.321 |
|
1999 |
Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, Crews CM. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proceedings of the National Academy of Sciences of the United States of America. 96: 10403-8. PMID 10468620 DOI: 10.1073/Pnas.96.18.10403 |
0.655 |
|
1999 |
Sin N, Kim KB, Elofsson M, Meng L, Auth H, Kwok BH, Crews CM. Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorganic & Medicinal Chemistry Letters. 9: 2283-8. PMID 10465562 DOI: 10.1016/S0960-894X(99)00376-5 |
0.638 |
|
1999 |
Meng L, Kwok BH, Sin N, Crews CM. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Research. 59: 2798-801. PMID 10383134 |
0.657 |
|
1998 |
Sin N, Meng L, Auth H, Crews CM. Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorganic & Medicinal Chemistry. 6: 1209-17. PMID 9784862 DOI: 10.1016/S0968-0896(98)00089-3 |
0.595 |
|
1998 |
Meng L, Sin N, Crews CM. The antiproliferative agent didemnin B uncompetitively inhibits palmitoyl protein thioesterase. Biochemistry. 37: 10488-92. PMID 9671519 DOI: 10.1021/Bi9804479 |
0.591 |
|
1997 |
Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proceedings of the National Academy of Sciences of the United States of America. 94: 6099-103. PMID 9177176 DOI: 10.1073/Pnas.94.12.6099 |
0.631 |
|
Show low-probability matches. |